Helius Medical Technologies Faces Nasdaq Delisting Risk Due to Stock Price Non-Compliance - TipRanks
| HSDT Stock | USD 0.75 0.09 13.64% |
Slightly above 56% of all Helius Medical's private investors are looking to take a long position. The analysis of overall sentiment of trading Helius Medical Technologies stock suggests that some investors are interested at this time. Helius Medical's investing sentiment can be driven by a variety of factors including economic data, Helius Medical's earnings reports, geopolitical events, and overall market trends.
Helius |
Helius Medical Technologies Faces Nasdaq Delisting Risk Due to Stock Price Non-Compliance TipRanks
Read at news.google.com
 |
Helius Medical Fundamental Analysis
We analyze Helius Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Helius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Helius Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Helius Medical is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Helius Medical Techn Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Helius Medical stock to make a market-neutral strategy. Peer analysis of Helius Medical could also be used in its relative valuation, which is a method of valuing Helius Medical by comparing valuation metrics with similar companies.
Peers
Helius Medical Related Equities
| HSCS | Heart Test | 2.87 | ||||
| RSLS | ReShape Lifesciences | 0.00 | ||||
| TIVC | Tivic Health | 0.00 | ||||
| NUWE | Nuwellis | 1.63 | ||||
| SINT | SINTX Technologies | 1.94 | ||||
| VVOS | Vivos Therapeutics | 2.31 | ||||
| SSKN | STRATA Skin | 2.86 | ||||
| ASAPF | Aurora Spine | 3.13 | ||||
| BBLG | Bone Biologics | 3.48 | ||||
| SGHT | Sight Sciences | 5.41 | ||||
| RPID | Rapid Micro | 10.50 | ||||
| BJDX | Bluejay Diagnostics | 11.75 |
Additional Tools for Helius Stock Analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.